Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 6,224 | 5,722 | 7,192 | 7,432 | 4,210 |
| Operating Income | -6,224 | -5,722 | -7,192 | -7,432 | -4,210 |
| Interest Expense | -17 | 1 | 2 | 3 | 2 |
| Other Income | 0 | 0 | -23 | 0 | 0 |
| Pre-tax Income | -6,208 | -5,723 | -7,217 | -7,435 | -4,212 |
| Income Tax | -2 | 5 | N/A | N/A | -2 |
| Net Income Continuous | -6,205 | -5,728 | -7,217 | -7,435 | -4,210 |
| Net Income | $-6,210 | $-5,723 | $-7,217 | $-7,435 | $-4,215 |
| EPS Basic Total Ops | -4.50 | -4.80 | -7.21 | -9.01 | -6.01 |
| EPS Basic Continuous Ops | -4.37 | -4.64 | -7.06 | -8.65 | -5.50 |
| EPS Diluted Total Ops | -4.50 | -4.80 | -7.21 | -9.01 | -6.01 |
| EPS Diluted Continuous Ops | -4.37 | -4.64 | -7.06 | -8.65 | -5.50 |
| EBITDA(a) | $-6,188 | $-5,853 | $-6,913 | $-7,384 | $-4,195 |